Four patients were below the age of 40 years; one had bilateral cancer; and three breast cancers were triple-negative according to ER, PR, and HER2 status The majority of study participants (62.0%) were diagnosed with cancer before the age of 50 years, with a family history reported in seven (54.0%) of these patients. The gene discussed is ERBB2; the disease is breast cancer.